Ionis Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Ionis Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 34% to $787,647,000. Profit margin reached -47%. Total operating expenses were $1,132,244,000.
Profit Margin
| 2014 | 214.16M | -38.98M | -18.2% |
|---|---|---|---|
| 2015 | 283.70M | -88.27M | -31.12% |
| 2016 | 346.62M | -86.55M | -24.97% |
| 2017 | 507.66M | -5.97M | -1.18% |
| 2018 | 599.67M | 273.74M | 45.65% |
| 2019 | 1.12B | 294M | 26.18% |
| 2020 | 729M | -487M | -66.8% |
| 2021 | 810M | -29M | -3.58% |
| 2022 | 587M | -270M | -46% |
| 2023 | 787.64M | -366.28M | -46.5% |
IONS Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 787.64M | 587M | 810M | 729M | 1.12B | 599.67M | 507.66M | 346.62M | 283.70M | 214.16M |
Cost of revenue | 9.13M | 14M | 11M | 12M | 4M | 1.82M | 374.64M | 344.32M | 322.29M | 241.75M |
Gross profit | 778.51M | 573M | 799M | 717M | 1.11B | 597.85M | 133.02M | 2.3M | -38.58M | -27.59M |
Operating exp. | ||||||||||
Research and development | 899.62M | 833M | 643M | 535M | 466M | 414.60M | 374.64M | 344.32M | 322.29M | 241.75M |
Selling and marketing | 0 | 700K | 15.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 1.13B | 984M | 829M | 889M | 753M | 659.22M | 483.13M | 392.93M | 359.46M | 261.89M |
Operating income | -353.73M | -411M | -30M | -172M | 366M | -61.37M | 24.53M | -46.31M | -75.76M | -47.73M |
Other income (expenses), net | 19.76M | 153M | -5.11M | 37.53M | -19M | 30.00M | -47.81M | 1.48M | -12.14M | -6.66M |
Income before tax | -333.96M | -258M | -30M | -170M | 347M | -76.15M | -23.27M | -83.62M | -87.90M | -54.39M |
Income tax expense | 32.32M | 12M | -1M | 317M | 44M | -291.14M | -5.98M | 2.93M | 372K | -15.40M |
Net income | -366.28M | -270M | -29M | -487M | 294M | 273.74M | -5.97M | -86.55M | -88.27M | -38.98M |
Earnings per share | ||||||||||
Basic EPS | -2.56 | -1.9 | -0.21 | -3.49 | 2.1 | 2.07 | -0.04 | -0.72 | -0.74 | -0.33 |
Diluted EPS | -2.56 | -1.9 | -0.21 | -3.49 | 2.06 | 2.04 | -0.04 | -0.72 | -0.74 | -0.33 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |